NasdaqGM:WVEPharmaceuticals
Wave Life Sciences (WVE) Stock Sinks As Losses Deepen And Revenue Dries Up
Wave Life Sciences dropped 4.3% to US$5.51 into the earnings close, yet the real story sat in the income statement rather than the ticker tape. The market focused on the red ink and pulled the stock lower, reacting to a quarterly net loss of US$69.4 million on just US$2.3 million of collaboration revenue.
For a high risk biotech that depends on research and development, the squeeze between heavy R&D and modest revenue is the headline. The question now is whether this margin strain reflects...